Table 3.
Hormone/Cytokine Concentrations.
| Variable | AA (n = 15) | PLA (n = 16) | Significance |
| PGF2α (pg·ml-1) | |||
| Day 0 | 164.6 ± 104.4 | 183.6 ± 96.0 | Group: 0.89 |
| Day 25 | 221.5 ± 153.2 | 281.5 ± 248.2 | Time: 0.06 |
| Day 50 | 209.7 ± 226.3 | 150.0 ± 104.5 | G × T: 0.14 |
| PGE2 (pg·ml-1) | |||
| Day 0 | 224.3 ± 145.7 | 293.6 ± 256.7 | Group: 0.97 |
| Day 25 | 288.5 ± 191.2 | 314.8 ± 236.1 | Time: 0.65 |
| Day 50 | 322.8 ± 281.2 | 219.9 ± 163.6 | G × T: 0.06 |
| tTEST (ng·ml-1) | |||
| Day 0 | 21.4 ± 24.8 | 14.0 ± 12.1 | Group: 0.25 |
| Day 25 | 18.7 ± 22.4 | 12.2 ± 7.1 | Time: 0.24 |
| Day 50 | 18.7 ± 18.3 | 12.2 ± 7.7 | G × T: 0.83 |
| fTEST (pg·ml-1) | |||
| Day 0 | 25.3 ± 14.7 | 24.9 ± 19.6 | Group: 0.82 |
| Day 25 | 23.1 ± 12.1 | 20.0 ± 12.1 | Time: 0.03 |
| Day 50 | 22.3 ± 13.6 | 22.3 ± 15.0 | G × T: 0.87 |
| CORT (μg·dl-1) | |||
| Day 0 | 34.0 ± 24.1 | 26.2 ± 10.6 | Group: 0.44 |
| Day 25 | 28.2 ± 20.0 | 23.1 ± 7.8 | Time: 0.06 |
| Day 50 | 36.8 ± 22.9 | 34.2 ± 35.8 | G × T: 0.57 |
| IL-6 (pg·ml-1) | |||
| Day 0 | 137.2 ± 69.6 | 120.1 ± 92.1 | Group: 0.63 |
| Day 25 | 138.0 ± 83.1b | 172.6 ± 90.5a | Time: 0.001 |
| Day 50 | 108.4 ± 48.6a | 127.0 ± 56.8 | G × T: 0.03 |
Values are expressed as means ± SD.
AA: Arachidonic acid, PLA: placebo, PGF2α: prostaglandin F2α, PGE2: prostaglandin E2, tTEST: total testosterone, fTEST: free testosterone, CORT: cortisol, IL-6: interleukin-6.
aSignificant within-group difference from baseline values, p < 0.05.
bSignificant group × time (G × T) interaction, p < 0.05.